2021-01-11,Illumina CEO Says Business Is Bouncing Back. The Gene Sequencer Sees New Opportunities.
2021-01-07,Kura Oncology to Participate in H.C. Wainwright BioConnect 2021 Conference
2021-01-06,Kura Oncology to Present at J.P. Morgan Healthcare Conference
2020-12-22,Is KURA A Good Stock To Buy According To Hedge Funds?
2020-12-11,Kura Oncology Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares
2020-12-10,Kura Oncology to Participate in the JMP Securities Hematology Summit
2020-12-08,Kura Oncology Announces Pricing of $300 Million Public Offering of Common Stock
2020-12-07,Kura Oncology Announces Commencement of Public Offering of Common Stock
2020-12-07,Here Are The Winners Of This Year's Biggest Blood Cancer Meeting
2020-12-05,Kura Oncology Presents First Clinical Data for Menin Inhibitor KO-539 at American Society of Hematology Annual Meeting
2020-11-24,"Kura Oncology to Host Virtual Investor Event on December 5, 2020"
2020-11-07,"Kura Oncology, Inc. (KURA) Q3 2020 Earnings Call Transcript"
2020-11-05,Kura Oncology Reports Third Quarter 2020 Financial Results
2020-11-05,"Kura Oncology, Inc. to Host Earnings Call"
2020-11-04,Kura Oncology to Participate in Three Upcoming Investor Conferences
2020-10-29,Kura Oncology to Report Third Quarter 2020 Financial Results
2020-10-26,Kura Oncology Reports Preclinical Results Showing Antitumor Activity of Tipifarnib in Combination with PI3K Inhibitor in Head and Neck Squamous Cell Carcinoma
2020-10-07,Kura Oncology Announces Preliminary Data for Menin Inhibitor KO-539 Accepted for Oral Presentation at ASH
2020-09-15,"Hedge Funds Never Been This Bullish On Kura Oncology, Inc. (KURA)"
2020-09-08,Kura Oncology to Participate in Two Upcoming Investor Conferences
2020-08-26,"Kura Oncology Clears Key Benchmark, Hitting 90-Plus RS Rating"
2020-08-26,Kura Oncology (KURA) Looks Good: Stock Adds 6.8% in Session
2020-08-25,Kura Oncology Appoints Dr. Stephen Dale as Chief Medical Officer
2020-08-06,Kura Oncology Reports Second Quarter 2020 Financial Results
2020-08-04,Kura Oncology to Present at Wedbush PacGrow Healthcare Virtual Conference
2020-07-30,Kura Oncology to Report Second Quarter 2020 Financial Results
2020-07-29,"How Many Kura Oncology, Inc. (NASDAQ:KURA) Shares Do Institutions Own?"
2020-07-17,"Did Hedge Funds Make The Right Call On Kura Oncology, Inc. (KURA) ?"
2020-06-16,"Hedge Funds Arent Done Buying Kura Oncology, Inc. (KURA)"
2020-06-11,Kura Oncology to Participate in JMP Securities Hematology & Oncology Forum
2020-05-29,Kura Oncology Reports Overall Survival Data from Phase 2 Trial of Tipifarnib in HRAS Mutant Head and Neck Squamous Cell Carcinoma
2020-05-13,Kura Oncology Announces Three Abstracts Accepted for Presentation at ASCO20 Virtual Scientific Program
2020-05-13,Edited Transcript of KURA earnings conference call or presentation 4-May-20 8:30pm GMT
2020-05-08,Kura Oncology Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares
2020-05-07,Kura Oncology to Present at BofA Securities Virtual Health Care Conference 2020
2020-05-06,Kura Oncology Announces Pricing of $125 Million Public Offering of Common Stock
2020-05-05,Kura Oncology Announces Commencement of Public Offering of Common Stock
2020-05-05,"Kura Oncology, Inc. (KURA) Q1 2020 Earnings Call Transcript"
2020-05-04,Kura Oncology Reports First Quarter 2020 Financial Results
2020-04-29,Kura Oncology to Report First Quarter 2020 Financial Results
2020-04-28,Why Kura Oncology Is Skyrocketing Today
2020-03-10,Edited Transcript of KURA earnings conference call or presentation 25-Feb-20 9:30pm GMT
2020-03-03,Kura Oncology Receives Fast Track Designation for Tipifarnib in T-Cell Lymphomas
2020-02-25,Kura Oncology Reports Fourth Quarter and Full Year 2019 Financial Results
2020-02-19,Kura Oncology to Participate in Three Upcoming Investor Conferences
2020-02-18,Kura Oncology to Report Fourth Quarter and Full Year 2019 Financial Results
2020-01-24,"The Daily Biotech Pulse: FDA Nod For Epizyme, Sonoma Explores Options For Dermatology Business, Roche's Cancer Drug Flunks Study"
2020-01-23,Kura Oncology Announces Transition of Chief Medical Officer
2020-01-21,3 Healthcare Stocks That Can Double in the Next Year
2020-01-09,Kura Oncology to Present at J.P. Morgan Healthcare Conference
2020-01-06,Kura Oncology Appoints Kirsten Flowers as Chief Commercial Officer
2019-12-16,Kura Oncology Receives Fast Track Designation for Tipifarnib in HRAS Mutant HNSCC and Provides Enrollment Guidance for AIM-HN Trial
2019-12-10,"Kura Oncology, Inc. (KURA): Hedge Funds Cant Make Up Their Minds"
2019-12-08,Kura Oncology Reports Clinical and Regulatory Updates for Tipifarnib in Angioimmunoblastic T-Cell Lymphoma
2019-11-26,Kura Oncology to Participate in Piper Jaffray Healthcare Conference
2019-11-25,Kura Oncology Requires Plenty of Patience by Investors
2019-11-15,Edited Transcript of KURA earnings conference call or presentation 5-Nov-19 9:30pm GMT
2019-11-12,Kura Oncology to Present at Stifel Healthcare Conference
2019-11-09,"Hedge Funds Have Never Been This Bullish On Kura Oncology, Inc. (KURA)"
2019-11-06,Kura Oncology Announces Upcoming Presentation at ASH Annual Meeting
2019-11-05,Kura Oncology Reports Third Quarter 2019 Financial Results and Provides Corporate Update
2019-11-04,Kura Oncology Appoints James Basta as Chief Legal Officer
2019-10-30,Kura Oncology to Report Third Quarter 2019 Financial Results
2019-10-29,Kura Oncology Reports Durable Anti-Tumor Activity in Phase 2 Trial of Tipifarnib in HRAS Mutant Head and Neck Cancer
2019-10-23,Kura Oncology Data Selected for Oral Presentation at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
2019-10-16,Kura Oncology Announces Upcoming Presentation at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
2019-10-15,Kura Oncology Expands Board of Directors with Appointment of Diane Parks
2019-10-01,Edited Transcript of KURA earnings conference call or presentation 1-Aug-19 8:30pm GMT
2019-09-16,Kura Oncology Doses First Patient in Phase 1 Clinical Trial of Menin-MLL Inhibitor KO-539 in Acute Myeloid Leukemia
2019-09-03,Kura Oncology Announces Positive Phase 2 Trial of Tipifarnib in HRAS Mutant Urothelial Carcinoma
2019-08-29,Kura Oncology to Participate in Two Upcoming Investor Conferences
2019-08-12,Kura Oncology Announces Appointment of Kathleen Ford as Chief Operating Officer
2019-08-07,Kura Oncology to Present at Wedbush PacGrow Healthcare Conference
2019-08-03,"Kura Oncology, Inc. (KURA) 2019 Q2 Earnings Call Transcript"
2019-07-25,Kura Oncology to Report Second Quarter 2019 Financial Results
2019-07-24,Kura Oncologys Menin-MLL Inhibitor KO-539 Receives Orphan Drug Designation from FDA for Treatment of Acute Myeloid Leukemia
2019-07-11,Kura Oncology Expands Protection for Tipifarnib with New U.S. and European Patents
2019-07-02,"Kura Oncology, Inc. (KURA) Shares March Higher, Can It Continue?"
2019-06-23,"Do Insiders Own Shares In Kura Oncology, Inc. (NASDAQ:KURA)?"
2019-06-23,"What Kind Of Investor Owns Most Of Kura Oncology, Inc. (NASDAQ:KURA)?"
2019-06-21,Kura Oncology Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares
2019-06-18,Kura Oncology Announces Pricing of $100 Million Public Offering of Common Stock
2019-06-18,Kura Oncology Announces Commencement of Public Offering of Common Stock
2019-06-18,"Is Kura Oncology, Inc. (KURA) A Good Stock To Buy?"
2019-06-17,"Company News For Jun 17, 2019"
2019-06-14,Kura Oncology Soars After Lymphoma Treatment Test Results
2019-06-14,Kura Oncology's stock soars toward record high after trial of lymphoma treatment achieves goal
2019-06-14,Kura Oncology Announces Positive Phase 2 Trial of Tipifarnib in Peripheral T-Cell Lymphoma
2019-05-15,Edited Transcript of KURA earnings conference call or presentation 7-May-19 8:30pm GMT
2019-05-09,"Heres What Hedge Funds Think About Kura Oncology, Inc. (KURA)"
2019-05-07,"Kura Oncology, Inc. (KURA) Q1 2019 Earnings Call Transcript"
2019-05-07,Kura Oncology: 1Q Earnings Snapshot
2019-05-07,Kura Oncology Reports First Quarter 2019 Financial Results and Highlights Upcoming Milestones
2019-04-30,Kura Oncology to Report First Quarter 2019 Financial Results
2019-04-25,Edited Transcript of KURA earnings conference call or presentation 5-Mar-19 9:30pm GMT
2019-04-02,"Kura Oncology Identifies Farnesylated Proteins Associated with CXCL12 Expression, Potential Biomarker of Clinical Benefit from Tipifarnib in Lymphoma Indications"
2019-03-29,"Detailed Research: Economic Perspectives on Five Below, INVESCO MORTGAGE CAPITAL INC, Amicus Therapeutics, Akamai Technologies, Kura Oncology, and Columbus McKinnon  What Drives Growth in Today's Competitive Landscape"
2019-03-27,"The Kura Oncology (NASDAQ:KURA) Share Price Has Soared 317%, Delighting Many Shareholders"
2019-03-06,Kura Oncology to Participate in Two Upcoming Investor Conferences
2019-03-05,"Kura Oncology, Inc. (KURA) Q4 2018 Earnings Conference Call Transcript"
